The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...

The Business Research Company's Abrysvo Or Arexvy Global market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Updated 2025 Market Reports Released: Trends, Forecasts to 2034 ...

The Moderna vaccine faces stiff competition from RSV vaccines Arexvy and Abrysvo, marketed by GSK and Pfizer, respectively. Moderna expects to launch 10 new products over the next three years and ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. A bunch of people I know (including me) have gotten sick ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...

GSK has reported new clinical data pointing to a benefit with its respiratory syncytial virus (RSV) vaccine Arexvy when used to treat a younger age group than the over-60s for whom it is approved.

Veronique Vial, French photographer, has lived in Los Angeles since 1989. Well known for her bestselling photography books Women before 10 a.m. and Men before 10 a.m., she is a celebrity, a travel, ...

The company is reducing the cost of its 2.5 milligram and 5 milligram Zepbound vials to $349 and $499 a month, respectively, according to a statement . That’s about $50 less than current prices.

Eli Lilly on Tuesday released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price to reach more patients without insurance coverage ...